Thousands tracked to see if tiny pacemaker stays safe over a decade

NCT ID NCT05270499

Ongoing Knowledge-focused Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 3,400 people who have already received the Aveir VR leadless pacemaker, a small device placed directly in the heart to treat slow heart rhythms. Researchers are using real-world medical records to check for complications up to 10 years after implantation. The goal is to confirm the device's long-term safety outside of clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aveir VR Leadless Pacemaker System
What this could lead to: If successful, this study will confirm the long-term safety of the Aveir VR leadless pacemaker, supporting its continued use for patients with slow heart rhythms.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results depend on real-world data quality and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrioventricular block Bradycardia cardiac rhythm disease Syncope, Vasovagal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRYTHMIA BRADYCARDIA CARDIAC PACEMAKER

Contacts and locations

Locations

Abbott

Sylmar, California, 91342, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.